OrbiMed’s Oscar Health OSCR Stock Holding History

OrbiMed’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-351,618	Closed	-$7.46M	–	131
2024 Q3	$7.46M	Buy	+351,618	New	+$6.33M	0.14%	83

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed's OSCR Position: Q4 2024 in Review

OrbiMed sold out of Oscar Health (OSCR) in Q4 2024, closing a stake of 351,618 shares — an estimated $7.46M sold.

OrbiMed first reported a position in OSCR in Q3 2024 and held it in 1 quarter. The position peaked at $7.46M in Q3 2024. 263 funds tracked by Wall St. Rank hold OSCR as of Q4 2024.

OrbiMed reported no remaining Oscar Health position as of Q4 2024 after selling out during the quarter.
OrbiMed sold 351,618 Oscar Health shares in Q4 2024, an estimated $7.46M.
OrbiMed first reported a position in Oscar Health in Q3 2024 and held it in 1 quarter.
OrbiMed's Oscar Health position peaked at $7.46M in Q3 2024.
263 funds tracked by Wall St. Rank held Oscar Health as of Q4 2024.

Based on OrbiMed's 13F filing for Q4 2024, filed 14 Feb 2025.